Shibin Zhou

Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.

ORCID: 0000-0003-1941-4425

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Cancer therapy with antibodies”.

Cancer therapy with antibodies

Nature reviews. Cancer(2024)10.1038/s41568-024-00690-x

N/A

3.6DataRank · unranked

227 citations

Maximilian F. Konig, Drew M. Pardoll, Chetan Bettegowda, Nickolas Papadopoulos, Katharine M. Wright +5 more

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

Science(2017)10.1126/science.aan6733

N/A

1.3DataRank · unranked

6550 citations

Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh +46 more

Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

Science(2020)10.1126/science.abb9601

N/A

0.977DataRank · unranked

673 citations

Adam H. Buchanan, Isaac Kinde, Andrew Warren, Ashley Honushefsky, Ariella Cohain +35 more

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers

Nature(2021)10.1038/s41586-021-03752-4

N/A

0.948DataRank · unranked

555 citations

Jiajia Zhang, Zhicheng Ji, Ajay Vaghasia, Boyang Zhang, Emily Han-Chung Hsiue +50 more

Targeting a neoantigen derived from a common TP53 mutation

Science(2021)10.1126/science.abc8697

N/A

0.880DataRank · unranked

351 citations

Katharine M. Wright, Jacqueline Douglass, Michael S. Hwang, Brian J. Mog, Alexander H. Pearlman +20 more

Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists

Journal of Clinical Investigation(2020)10.1172/jci139642

N/A

0.721DataRank · unranked

121 citations

Michael Powell, Verena Staedtke, Ren-Yuan Bai, David L. Thomas, Nicole Fischer +13 more

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

Journal of Clinical Investigation(2021)10.1172/jci146922

N/A

0.683DataRank · unranked

94 citations

Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Laurene S. Cheung, Dilshad Choudhury +23 more

Targeting loss of heterozygosity for cancer-specific immunotherapy

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2022410118

N/A

0.652DataRank · unranked

76 citations

Brian J. Mog, Jacqueline Douglass, Alexander H. Pearlman, Emily Han-Chung Hsiue, Suman Paul +10 more

TCR β chain–directed bispecific antibodies for the treatment of T cell cancers

Science Translational Medicine(2021)10.1126/scitranslmed.abd3595

N/A

0.612DataRank · unranked

58 citations

Alexander H. Pearlman, Jacqueline Douglass, Brian J. Mog, Emily Han-Chung Hsiue, Michael S. Hwang +15 more

TRBC1-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature(2024)10.1038/s41586-024-07233-2

N/A

0.574DataRank · unranked

45 citations

Jiaxin Ge, Brian J. Mog, Bum Seok Lee, Alexander H. Pearlman, Michael S. Hwang +22 more

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens

Nature Communications(2021)10.1038/s41467-021-25605-4

N/A

0.553DataRank · unranked

39 citations

Michelle S. Miller, Puchong Thirawatananond, Jacqueline Douglass, Katharine M. Wright, Emily Han-Chung Hsiue +17 more

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities

Science Translational Medicine(2024)10.1126/scitranslmed.adg7123

N/A

0.489DataRank · unranked

25 citations

Nikita Marcou, Sarah R. DiNapoli, Alexander H. Pearlman, Tushar D. Nichakawade, Michael S. Hwang +19 more

Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen

Nature Communications(2023)10.1038/s41467-023-40821-w

N/A

0.489DataRank · unranked

25 citations

Sarah R. DiNapoli, Michelle S. Miller, P. Aitana Azurmendi, Xiaowei Zhao, Zhiheng Yu +17 more

An isogenic cell line panel for sequence-based screening of targeted anticancer drugs

iScience(2022)10.1016/j.isci.2022.104437

N/A

0.406DataRank · unranked

14 citations

Nicolas Wyhs, Surojit Sur, Blair Ptak, Maria Popoli, Laura Dobbyn +7 more

Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape

eLife(2024)10.7554/elife.95952

N/A

0.406DataRank · unranked

10 citations

Surojit Sur, Laura Dobbyn, Evangeline Watson, Joshua D. Cohen, Blair Ptak +12 more

Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.28.573594

N/A

0.331DataRank · unranked

4 citations

Surojit Sur, Laura Dobbyn, Evangeline Watson, Joshua D. Cohen, Blair Ptak +12 more

The rapid and highly parallel identification of antibodies with defined biological activities by SLISY

Nature Communications(2023)10.1038/s41467-022-35668-6

N/A

0.312DataRank · unranked

7 citations

Austin K. Mattox, P. Aitana Azurmendi, Ilias Christodoulou, Katharine M. Wright, Maria Popoli +11 more

Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.19.682634

N/A

0.269DataRank · unranked

5 citations

Yuanxuan Xia, Brian J. Mog, Colin Gliech, Elana Shaw, Dylan P. Ferris +25 more

NXPE1 alters the sialoglycome by acetylating sialic acids in the human colon

Nature Communications(2025)10.1038/s41467-025-59671-9

N/A

0.241DataRank · unranked

4 citations

Ashley L. Cook, Surojit Sur, Laura Dobbyn, Maria Popoli, Sana Khalili +9 more

identifying cancer patients from GC-patterned fragment ends of cell-free DNA

medRxiv(2022)10.1101/2022.08.02.22278319

N/A

0.222DataRank · unranked

3 citations

Mahmoud Summers, Joshua D. Cohen, Yuxuan Wang, Nadine Nehme, Maria Popoli +17 more

TRBC2-targeting antibody–drug conjugates for the treatment of T cell cancers

Nature Cancer(2025)10.1038/s43018-025-01069-z

N/A

0.165DataRank · unranked

2 citations

Joshua Urban, Sarah R. DiNapoli, Bum Seok Lee, Taha Ahmedna, Tushar D. Nichakawade +26 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2024)10.7554/elife.94488

N/A

0.111DataRank · unranked

1 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.23.550207

N/A

0.104DataRank · unranked

1 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cells

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.64898/2025.12.09.691975

N/A

0.104DataRank · unranked

1 citations

Brian J. Mog, Michael S. Hwang, Jordina Rincón-Torroella, Sarah R. DiNapoli, Suman Paul +11 more

Six events that shaped antibody approvals in oncology

Frontiers in Immunology(2025)10.3389/fimmu.2025.1533796

N/A

0DataRank · unranked

9 citations

Shibin Zhou, Suman Paul

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2024)10.7554/elife.94488.1

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Setting “cold” tumors on fire: Cancer therapy with live tumor-targeting bacteria

Med(2024)10.1016/j.medj.2024.11.002

N/A

0DataRank · unranked

10 citations

Dinh-Huy Nguyen, Jung-Joon Min, Shibin Zhou, Simin Manole

An Isogenic Cell Line Panel for Sequence-based Screening of Targeted Anti-cancer Drugs

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.06.455336

N/A

0DataRank · unranked

0 citations

Nicolas Wyhs, Surojit Sur, Blair Ptak, Maria Popoli, Laura Dobbyn +7 more

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

eLife(2025)10.7554/elife.94488.3

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian J. Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more

Reviewer #2 (Public review): ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

(2024)10.7554/elife.94488.2.sa1

N/A

0DataRank · unranked

0 citations

Marco Dal Molin, Brian Mog, Gyuri Han, Evangeline Watson, Nicolas Wyhs +12 more